StockIQ.techMedpace Holdings, Inc. (MEDP) Stock Analysis
Free AI-powered analysis and research for Medpace Holdings, Inc. stock
Sector: Healthcare
MEDP snapshot
Data as of 3 Nov 2026 close. Updated daily.
Medpace Holdings, Inc. scores 79/100 on StockIQ's model, which reads as strongly positive signals overall. The price is above its 200-day average and at 92% of its 52-week range, up 12.7% over the past year. Latest reported figures show a profit margin of 18.2%, return on equity of 117.9% and revenue growth of +8.5%.
What is driving the score
- RSI Neutral: +5
- Strong Uptrend: +12
- MACD Bullish: +8
- High P/E (36.2): -10
- Good Profit Margin (18.2%): +5
- Low Debt (0.29 D/E): +8
- Low Liquidity (0.83 Current Ratio): -10
- Excellent ROE (117.9%): +8
- High P/B (31.17): -5
- Strong Long-term Uptrend: +8
- Up Over 1 Year (+12.7%): +3
- Low Volume (0.2x): -3
Automated, general information only – not financial advice. Scores can be wrong. How the score works
Full MEDP report
Medpace Holdings, Inc. (MEDP) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.
Analyze MEDP Now →📰 Latest Update
All You Need to Know About Medpace (MEDP) Rating Upgrade to Buy
Mon, October 26, 2026 at 3:00 PM UTC 4 min read
Medpace (MEDP) received a rating upgrade to "Buy" from analysts, reflecting increased confidence in the company's growth potential and financial performance. This upgrade is significant for investors as it suggests a positive outlook for Medpace's stock, potentially leading to higher demand and increased share value. Investors may view this as an opportunity to capitalize on the company's strong position in the clinical research industry.